BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8605101)

  • 21. Increase of HLA-DR-positive natural killer cells in peripheral blood from patients with IgA nephropathy.
    Yano N; Endoh M; Nomoto Y; Sakai H; Rifai A
    Hum Immunol; 1996 Aug; 49(1):64-70. PubMed ID: 8839777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of epidermal growth factor receptor messenger RNA in human colorectal carcinomas assessed by non-radioactive in-situ hybridization.
    Komuta K; Koji T; Izumi S; Matsumoto T; Kohara N; Motojima K; Kanematsu T; Nakane PK
    Eur J Surg Oncol; 1995 Jun; 21(3):269-75. PubMed ID: 7781795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of HLA-DR antigen on head and neck carcinomas--immunohistological study].
    Samukawa T
    Nihon Jibiinkoka Gakkai Kaiho; 1993 Jan; 96(1):88-97. PubMed ID: 8459313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection.
    Heriot AG; Marriott JB; Cookson S; Kumar D; Dalgleish AG
    Br J Cancer; 2000 Mar; 82(5):1009-12. PubMed ID: 10737381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
    Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-gamma and tumor necrosis factor-alpha in human thyroid carcinoma cells.
    Rahat MA; Chernichovski I; Lahat N
    Int Immunol; 2001 Nov; 13(11):1423-32. PubMed ID: 11675374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
    Carrel S; Schmidt-Kessen A; Giuffrè L
    Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes.
    Alvaro-Gracia JM; Zvaifler NJ; Firestein GS
    J Clin Invest; 1990 Dec; 86(6):1790-8. PubMed ID: 2174906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of HLA-DR antigen in monocytes from colorectal cancer patients by in vitro treatment with human recombinant interferon-gamma.
    Novellino PS; Trejo YG; Beviacqua M; Bordenave RH; Rumi LS
    J Investig Allergol Clin Immunol; 2000; 10(2):90-3. PubMed ID: 10879996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis.
    Andersen SN; Rognum TO; Lund E; Meling GI; Hauge S
    Br J Cancer; 1993 Jul; 68(1):80-5. PubMed ID: 8318425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined expression of HLA-DR antigen and proliferating cell nuclear antigen correlate with colorectal cancer prognosis.
    Kunihiro M; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 1998; 55(4):326-33. PubMed ID: 9663422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local immune response to tumor invasion in esophageal squamous cell carcinoma. The expression of human leukocyte antigen-DR and lymphocyte infiltration.
    Sadanaga N; Kuwano H; Watanabe M; Maekawa S; Mori M; Sugimachi K
    Cancer; 1994 Jul; 74(2):586-91. PubMed ID: 8033037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta.
    Dansky-Ullmann C; Salgaller M; Adams S; Schlom J; Greiner JW
    Cytokine; 1995 Feb; 7(2):118-29. PubMed ID: 7780031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of pulmonary fibrosis in interstitial lung disease. Alveolar macrophage PDGF(B) gene activation and up-regulation by interferon gamma.
    Shaw RJ; Benedict SH; Clark RA; King TE
    Am Rev Respir Dis; 1991 Jan; 143(1):167-73. PubMed ID: 1898843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis.
    Håkansson L; Adell G; Boeryd B; Sjögren F; Sjödahl R
    Br J Cancer; 1997; 75(3):374-80. PubMed ID: 9020482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
    Levy EM; Bianchini M; Von Euw EM; Barrio MM; Bravo AI; Furman D; Domenichini E; Macagno C; Pinsky V; Zucchini C; Valvassori L; Mordoh J
    Int J Oncol; 2008 Mar; 32(3):633-41. PubMed ID: 18292941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant interferon-gamma increases HLA-DR synthesis and expression.
    Basham TY; Merigan TC
    J Immunol; 1983 Apr; 130(4):1492-4. PubMed ID: 6403609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Suppression of gamma-interferon induced HLA-DR antigen expression on normal and transformed keratinocytes by 1,25 (OH)2 vitamin D3].
    Tone T; Eto H; Katsuoka K; Nishioka K; Nishiyama S
    Nihon Hifuka Gakkai Zasshi; 1991 Apr; 101(5):519-25. PubMed ID: 1909764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterising the prognostic potential of HLA-DR during colorectal cancer development.
    Dunne MR; Phelan JJ; Michielsen AJ; Maguire AA; Dunne C; Martin P; Noonan S; Tosetto M; Geraghty R; Fennelly D; Sheahan K; Ryan EJ; O'Sullivan J
    Cancer Immunol Immunother; 2020 Aug; 69(8):1577-1588. PubMed ID: 32306077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.